1Myslak M, Amer H, Morales P, et al. Interpreting Post-Transplant Proteinuria in Patients with Proteinuria Pre-Transplant. Am J Transplant, 2006,6 : 1660 - 1665.
2Tullius SG, Reutzel-Selke A, Egerrnann F, et al. Contribution of pro-longed ischemia and donor age to chronic renal atlograft dysfunction. J Am Soc Nephrol, 2000,11:1317 -1324.
3de Vries B, Walter SJ, Peutz-Kootstra CJ, et al. The mannose-bind- ing lectin-pathway is involved in complement activation in the course of renal ischemia-rcperfusion injury. Am J Pathol, 2004,165 : 1677 - 1688.
4Matas AJ. Recurrent disease after kidney transplantation--it is time to unite to address this probleml Am J Transplant, 2006,6:2527 - 2528.
5Bumgardner GL, Amend WC, Ascher NL, et al. Single-center long- term resuhs of renal transplantation for lgA nephropathy. Transplantation, 1998,65:1053 - 1060.
6Odum J, Peh CA, Clarkson AR, et al. Recurrent mesanglal IgA nephritis following renal transplantation. Nephrol Dial Transplant, 1994,9:309 - 312.
7Floege J. Recurrent IgA nephropathy afler renal transplantation. Serain Nephrol, 2004,24 : 287 - 291.
8Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med, 2002,347:103 -109.
9Sharma R, Sharma M, McCarthy ET, et al. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int, 2000,58:1973 - 1979.
10Coward RJ, Foster RR, Patton D, et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephria, Podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol, 2005,16:629 - 637.
4MOK C C,YING K Y,TANG S,et al.Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis[J].Arthritis Rheum,2004,50(8):2559-2568.
1Morrissey PE, Yango AF. Renal transplantation., old er recipients and donors[J]. Clin Geriatr Med,2006,22 (3) :687-707.
2Alnimri M, Laftavi MR, Kohli R,et al. African-Amer- ican women and older patients are at risk for a greater decline in renal function following living kidney dona- tion[J]. Transplant Proc, 2011, 43(2) :512-515.
3Miles CD,Schaubel DE ,Liu D,et al. The role of donor- recipient relationship in long-term outcomes of living donor renal transplantation[J]. Transplantation,2008, 85 (10) : 1483-1488.
4Tabakgyic M, Mesic E, Tmacevic S,et al. Hyperten- sion and donor age in l.iving-related kidney transplanta- tion[J]. Acta Med Croatica,2010,64(3)：175-181.
5Young A,Kim SJ,Speechley MR,et al. Accepting kid neys from older living donors: impact on transplant re- cipient outcomes [J]. Am J Transplant, 2011, 11 ( 4 ) : 743-750.
6Nauta FL, Bakker SJ, van Oeveren W,et al. Albumin- uria, proteinuria, and novel urine biomarkers as pre- dictors of long-term allograft outcomes in kidney trans- plant recipients[J]. Am J Kidney Dia,2011,57(5) =733- 743.
7Hemdndez D,P6rez G, Marrero D,et al. Early associ ation of low-grade albuminuria and allograft dysfunc tion predicts renal transplant outcomes[J]. Trans plantation, 2012,93 (3) : 297-303.
8Halimi JM, Buchler M. A1-Najjar A,et al. Urinary al- bumin excretion and the risk of graft loss and death inproteinuric and non-proteinuric renal transplant recip- ients[J] Am J Transplant, 2007, 7(3) ：618-625.
9Matas AJ. Recurrent disease after kidney transplantation-- it is time to unite to address this problem! [J]. Am J Transplant, 2006,6(11) : 2527-2528.
10Racusen LC, Solez K,Colvin R. Fibrosis and atrophy in the renal allograft:interim report and new directions[J]. Am J Transplant, 2002,2 (3) .. 203-206.
